Inhalation of Moli1901 in Patients With Cystic Fibrosis
- 1 May 2007
- journal article
- research article
- Published by Elsevier BV in Social psychiatry. Sozialpsychiatrie. Psychiatrie sociale
- Vol. 131 (5), 1461-1466
- https://doi.org/10.1378/chest.06-2085
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Determination of the tissue distribution and excretion by accelerator mass spectrometry of the nonadecapeptide 14C-Moli1901 in beagle dogs after intratracheal instillationChemico-Biological Interactions, 2005
- Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: Results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosisPediatric Pulmonology, 2005
- Cystic fibrosisThe Lancet, 2003
- Three‐minute step test to assess exercise capacity in children with cystic fibrosis with mild lung diseasePediatric Pulmonology, 2003
- Pharmacokinetics and tissue distribution of the nonadecapeptide Moli1901 in rats and miceXenobiotica, 2003
- The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot studyEuropean Respiratory Journal, 1999
- Duramycin Increases Intracellular Calcium in Airway EpitheliumMembrane Biochemistry, 1993
- Extracellular ATP and UTP Induce Chloride Secretion in Nasal Epithelia of Cystic Fibrosis Patients and Normal Subjects in vivoSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1992
- Standardization of Spirometry—1987 UpdateAmerican Review of Respiratory Disease, 1987
- Interaction of duramycin with artificial and natural membranesBiochemistry, 1985